WendyColleenMooreMD

Asthma & COPD

Professor, Internal Medicine Director, Airways Clinical Research Center Director, Clinical Pulmonary Research Section on Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest School of Medicine

Join to view full profile

Dr. Moore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moore's full profile

Already have an account?

Office
Airways Clinical Research Center
2000 W First Street, suite 400
Winston Salem, NC 27104
Phone+1 336-713-8550

Fax+1 336-713-8532

Education & Training

University of MarylandFellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1997
University of MarylandResidency, Internal Medicine, 1991 - 1994
University of Maryland School of MedicineClass of 1991, MD
University of Maryland Baltimore CountyBA, Biological Sciences, 1982 - 1986

Certifications & Licensure

NC State Medical License 2000 - 2025
MD State Medical License 1994 - 2001
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Clinical Trials

Asthma Clinical Research Network (ACRN) Start of enrollment: 1993 Sep 01
Withdrawn
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) Start of enrollment: 2004 Dec 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA) Start of enrollment: 2006 Jun 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT) Start of enrollment: 2007 Jun 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) Start of enrollment: 2008 May 01
Completed
Phase 3
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma Start of enrollment: 2009 Nov 01
Completed
Phase 2
Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma Start of enrollment: 2011 Apr 01
Completed
Phase 3
Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment Start of enrollment: 2012 Oct 01
Completed
Not Applicable
Severe Asthma Research Program Start of enrollment: 2012 Oct 01
Active, not recruiting
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma Start of enrollment: 2012 Oct 08
Completed
Phase 3
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects Start of enrollment: 2012 Sep 28
Completed
Phase 3
Severe Asthma Research Program - Wake Forest University Start of enrollment: 2012 Dec 01
Completed
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma Start of enrollment: 2013 Sep 19
Completed
Phase 3
Best African American Response to Asthma Drugs Start of enrollment: 2014 Feb 01
Completed
Phase 3
Study of COPD Subgroups and Biomarkers Start of enrollment: 2010 Nov 01
Active, not recruiting
Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy Start of enrollment: 2014 Apr 28
Completed
Phase 3
Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) Start of enrollment: 2014 Aug 05
Completed
Phase 3
Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma Start of enrollment: 2016 Jan 27
Completed
Phase 2
Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) Start of enrollment: 2017 Jul 17
Active, not recruiting
Phase 2
Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE) Start of enrollment: 2018 Feb 27
Recruiting
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma Start of enrollment: 2018 Aug 01
Completed
Phase 3
A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma Start of enrollment: 2018 Aug 29
Completed
Phase 3
GB001 in Adult Subjects With Moderate to Severe Asthma Start of enrollment: 2018 Oct 22
Completed
Phase 2
Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma Start of enrollment: 2019 Jan 25
Completed
Phase 3
Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics Start of enrollment: 2019 Oct 17
Recruiting
Phase 4
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study Start of enrollment: 2019 Dec 19
Recruiting
Phase 2
American Lung Association (ALA) Lung Health Cohort Start of enrollment: 2021 Oct 29
Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE) Start of enrollment: 2021 Sep 08
Recruiting
Join now to see all

Publications & Presentations

PubMed

46 citations
Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways.
Xingnan Li, Stephanie A. Christenson, Brian D. Modena, Huashi Li, William W. Busse
The Journal of Allergy and Clinical Immunology. 2021-03-01
183 citations
Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program.
Nizar N. Jarjour, Serpil C. Erzurum, Eugene R. Bleecker, William J. Calhoun, Mario Castro
American Journal of Respiratory and Critical Care Medicine. 2012-02-15
69 citations
Asthma Is More Severe in Older Adults
Joe Zein, Raed A. Dweik, Suzy A. A. Comhair, Eugene R. Bleecker, Wendy C. Moore
Plos One. 2015-07-22